Triochem Products Ltd. — Interim / Quarterly Report 2021

Feb 12, 2021

MANIJFACTURERS OF IITHICAL PHARMACEUTICAL PRODUCTS Registered Office: 4th FLoor, Sambava Chambers, Sir. P. M. Road, Fort, Munbal, Malarashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 EE-]EET=Ri%-=EEEn ```.~-,, Fan 00 91 (22) 2202 4657 E-mall: info@amDhrav.com Wdbsite: www.triochemoroducts.com Corporate Identity Number: L24249MH 1972PLC015544

Ref No: TPL PP 201228 2020; 12th February 2021

To BSE Limited Corporate Relationship Department, Phiroze ]eejeebhoy Towers, Dalal Street, Fort` Munbai: 400 001. Security Code No. 512101 -ISIN No.: INE331E01013.

Dear Sir / Madam,

Sub: Submission of Unaudited Financial Results for the Ouarter and Nine Months ended Slat December 2020

We refer to our letter dated 2nd February 2021 on the captioned subject.

Pursuant to Regulation 30 and 33 of SEBI Qisting Obligations and Disclosure Requirements) Regulations, 2015, In this subject, we wish to inform you that the Board of Director of the Company at its meeting held today i.e., Friday, 12th February 2021 have interalia considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended Slat December 2020 duly revieved by the Audit Committee.

The said financial results, duly signed by the Director & CEO of the company along with the statutory auditor's report are enclosed for your perusal and records. -

Also, informed that the audited financial results in prescribed format will be published in "Free Press Tournal" and "Navshakei" newspaper, as required. Please take the same in you record.

Thandngyou,

your faithfully,

For TRIOCHEM PRODUCTS LIMITED

iRAMUS.DEORA

DIRECTOR & CEO DIN: 00312369 Encl.: as above

Kanu I)oshi Associates LLP

Chartered Accountants

Mumbei Address : 203, The Siimmit, Hanuman Road, Western Express Highway, vile Parie (E), Mumbai - 400 057 T : 022-2615 0100 / 111 / 112 . F : 022 2615 0113

Pune Address : 123, Sohrab Hall, 21 Sassoon Road, Opp. Jehangir Hospital, Pune -411001. T : 020 4906 7177 E : info@kdg.co.in . W : www.kdg.co.in

Independent Auditor.s Review Report on Unaudited Quarterly Financial Results of the Company Pursuant to the Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended)

TO'

The Board of Directors of TRIOCHEM PRODUCTS LIMITED ("Company")

• 1. We have reviewed the accompanying statement of unaudited financial results of TRIOCHEM PRODUCTS LIMITED ("Company'') for the quarter and nine months ended December 31, 2020 being submitted by the Company pursuant to Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), including relevant circulars issued by SEBl from time to time. The statement is the responsibility of the Company's management and has been approved by Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review of the Statement, which has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("lnd As 34"), specified under Section 133 of the Companies Act, 2013, SEBI Circular CIR/CFD/PAC/62/2016 dated 5 July 2016 (hereinafter referred to as 'the SEBI Circular'), and other accounting principles generally accepted in India.
• 1. We conducted our review of the statement in accordance with the Standard on Review Engagement (SRE) 2410, `Review of Interim Financial Information performed by Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and an analytical procedure applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.
• 1. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable Indian Accounting Standards (Ind AS) and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement.

For Kanu Doshi Associates LLP Chartered Accountants Firm Registration No: 104746WAVI00096

KUNALSUMANT¥¥#i===,¥ir##ae VAKH A R [A ¥±+r®==:in-w cmanlJ\L||\<Is',a+-

Kunal Vakharia Partner Membership No.: 148916 UDIN: 21148916AAAABR3677

Place: Mumbai Date: 12th February 2021

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2202 4657 E-mall: info@amphray.com Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

		TRIOCHEM PRODUCTS LIMITED
Registered Office : Sambava Chamber, 4th Floor, Sir P M Road, Fort, Mumbai - 400 001.
Website: www.triochemproducts.com
CIN: L24249MH1972PLC015544
STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER, 2020
							(Rs in Lakh) Except EPS
Sr.	Particulars	Quarter Ended				Nine Month Ended	Year Ended
No.		31-Dec-20	30-Sep-20	31-Dec-19	31-Dec-20	31-Dec-19	31-Mar-20
		(Unaudited)	(Unaudited)	(Unaudited)	(Unaudited)	(Unaudited)	(Audited)
1	Income (a) Revenue from Operations	394.50	225.86	541.16	620.36	855.52	2,003.18
	(b) Other Income	0.16	4.38	12.93	5.84	13.25	46.63
	Total Income From Operations	394.66	230.24	554.09	626.20	868.77	2.049.81
	Expenses
	(a) Cost of Materials Consumed	(0.00)	226.06	424.70	644.54	424.70	968.86
	(b) Purchase of stock in trade			4.78		4.78	37.55
	(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade	360.19	(47.76)	(99.57)	(111.88)	102.98	354.67
	(d) Employees Benefit Expenses	16.74	16.89	17.04	50.52	51.92	82.33
	(e) Finance Costs	2.47	4.97	9.36	9.53	17.19	22.97
	(f) Depreciation and Amortisation Expenses	3.46	3.46	4.21	10.34	12.57	16.68
	(g) Other Expenditure	21.40	33.79	27.33	75.23	84.93	111.57
	Total expenses	404.26	237.41	387.85	678.28	699.08	1.594.63
3	Profit before exceptional items and tax	(9.60)	(7.17)	166.24	(52.08)	169.69	455.18
4	Exceptional items
5	Profit/ (Loss) before tax	(9.60)	(7.17)	166.24	(52.08)	169.69	455.18
6	Tax Expense
	(a) Current tax	(0.00)		41.73	0.02	44.02	117.33
	(b) Deferred tax	(2.42)	(1.73)	1.71	(12.98)	(1.80)	(2.43)
	Total tax expenses	(2.43)	(1.73)	43.44	(12.97)	42.22	114.90
$\vert$ 7	Net Profit/ (Loss) for the period	(7.18)	(5.43)	122.80	(39.12)	127.47	340.28
	Other Comprehensive Income (Net of Taxes)
	(A)(i). Items that will be reclassified to profit or loss	٠
	(ii). Income tax relating to items that will be reclassified to profit or loss	٠	٠		٠	٠	٠
	(B)(i). Item that will not be reclassified to profit or loss	0.43	(1.06)	(0.03)	(0.52)	(0.32)	(0.30)
	(ii). Income tax relating to items that will not be reclassified to profit or loss	(0.11)	0.27		0.13	0.08	0.08
	Total other Comprehensive Income (net of taxes)	0.32	(0.79)	(0.03)	(0.39)	(0.24)	(0.22)
9	Total Comprehensive Income for the period	(6.85)	(6.22)	122.77	(39.50)	127.23	340.06
10	Paid-up equity share capital (Face Value of ₹ 10/- per share)	24.50	24.50	24.50	24.50	24.50	24.50
11	Other equity as per Balance Sheet of previous accounting year						1,193.14
12	Earnings per equity share (EPS) (of Rs. 10/- each) (not annualised)
	Basic / Diluted EPS (in Rs.)	(2.93)	(2.22)	50.12	(15.97)	52.03	138.89

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2202 4657 E-mall: info@amphray.com Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

Notes:
	1) The above unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 12th
	February, 2021. The Statutory auditors of the company has carried out a limited review of aforesaid results.
	2) The Audited financial results have been prepared in accordance with Indian Accounting Standards (Ins AS), the provisions of the Companies Act, 2013
	(the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI).
	3) The Company operates in single segment only, i.e. chemical and pharmaceuticals: therefore, disclosure requirement of Indian Accounting Standard
	(IND AS-108) "Segment Reporting" is not applicable.
	4) Operations during the quarter continued to be impacted by measures to contain covid-19 pandemic. The business gathered momentum, though
	recovery has been gradual and partial. Accordingly, the results for the quarter are not comparable with those for for the previous quarter and
	corresponding quarter of previous year. Based on the information available upto date, the Group expects to recover the carrying value of its assets.
	5) The date of implementation of the Code on Wages, 2019 and the Code on Social Security 2020 is yet to be notified by the Government. The Ministry of
	Labour and Employment has released draft rules for the Code on Social Security 2020 on November 13, 2020, and has invited suggestions from
	Stakeholders which are under active consideration by the Ministry. The Company will assess the impact of these codes and give effect in the financial
	result when the Rules/Schemes thereunder are notified.
	6) The Corresponding figures of the previous quarter / year have been regrouped, recasted and reclassified to make them comparable wherever necessary.
	FOR TRIOCHEM PRODUCTS LIMITED
	RAMU S. DEORA

Place: Mumbai Dated: 12th February, 2021

DIRECTOR & CEO

Registered Office : Sambava Chamber, 4th Floor, Sir P M Road, Fort, Mumbai - 400 001.

Website: www.triochemproducts.com

CIN: L24249MH1972PLC015544

EXTRACT OF STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER, 2020

	(Rs in Lakh) Except EPS
Sr.	Particulars	Quarter Ended			Nine Month Ended		Year Ended
No.		31-Dec-20	30-Sep-20	31-Dec-19	31-Dec-20	31-Dec-19	31-Mar-20
				(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited)			(Audited)
	Net Operating Income	394.66	230.24	554.09	626.20	868.77	2.049.81
2	Profit / (Loss) for the period (before Interest, Depreciation, Taxes, Exceptional and / or Extraordinary items)	(3.68)	1.26	179.81	(32.22)	199.45	494.83
$\overline{3}$	Profit / (Loss) for the period before tax (after Exceptional and / or Extraordinary items)	(9.60)	(7.17)	166.24	(52.08)	169.69	455.18
4	Profit / (Loss) for the period after tax (after Exceptional and / or Extraordinary items)	(7.18)	(5.43)	122.80	(39.12)	127.47	340.28
5	Total Comprehensive Income for the period [Comprising Profit / (Loss) for the period (after tax) and Other Comprehensive Income	0.32	(0.79)	(0.03)	(0.39)	(0.24)	(0.22)
6	Equity share capital (Face value of Rs.10/- per share)	24.50	24.50	24.50	24.50	24.50	24.50
٠,	Reserve (excluding Revaluation Reserves as shown in the Balance) Sheet of previous year)						1.193.14
$\mathfrak{z}$	Earnings per equity share (EPS) (of Rs. 10/- each) (for continuing and discontinued operations)
	a) Baisc (not annualized)	(2.93)	(2.22)	50.12	(15.97)	52.03	138.89
	b) Diluted (not ammualized)	(2.93)	(2.22)	50.12	(15.97)	52.03	138.89
Notes:
	1) The above unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 12th
	February, 2021. The Statutory auditors of the company has carried out a limited review of aforesaid results.

2) The Audited financial results have been prepared in accordance with Indian Accounting Standards (Ins AS), the provisions of the Companies Act, 2013 (the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI).

3) The Company operates in single segment only, i.e. chemical and pharmaceuticals; therefore, disclosure requirement of Indian Accounting Standard (IND) AS-108) "Segment Reporting" is not applicable.

4) Operations during the quarter continued to be impacted by measures to contain covid-19 pandemic. The business gathered momentum, though recovery has been gradual and partial. Accordingly, the results for the quarter are not comparable with those for the previous quarter and corresponding quarter of previous year. Based on the information available upto date, the Group expects to recover the carrying value of its assets.

5) The date of implementation of the Code on Wages, 2019 and the Code on Social Security 2020 is yet to be notified by the Government. The Ministry of Labour and Employment has released draft rules for the Code on Social Security 2020 on November 13, 2020, and has invited suggestions from Stakeholders which are under active consideration by the Ministry. The Company will assess the impact of these codes and give effect in the financial result when the Rules/Schemes thereunder are notified.

6) The Corresponding figures of the previous quarter / year have been regrouped, recasted and reclassified to make them comparable wherever necessary.

FOR TRIOCHEM PRODUCTS LIMITED

Place: Mumbai Dated: 12th February, 2021

RAMU S. DEORA